<DOC>
	<DOC>NCT01563679</DOC>
	<brief_summary>This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies. Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.</brief_summary>
	<brief_title>Analysis of Percutaneous Ablations for Cancer Treatment</brief_title>
	<detailed_description>The efficacy of the percutaneous and transarterial treatments for solid tumors will be studied. Prospective study on patients who receive percutaneous locoregional therapies, including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical ablation for treatment of cancer will be performed. Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT, MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be reviewed. Patient survival, treatment responses, complications after the therapy will be collected from clinic visits and clinical encounters. Patient overall performance status before and after procedures will be assessed using the Quality of Life questionnaire (SF-36â„¢ Health Survey).</detailed_description>
	<criteria>18yrs of age Cancer diagnosis Candidate for Locoregional therapy Willingness to sign informed consent Unable to sign informed consent Patients not eligible for locoregional therapies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>cancer</keyword>
	<keyword>locoregional therapies</keyword>
	<keyword>RFA</keyword>
	<keyword>Cryoablation</keyword>
	<keyword>Microwave ablation</keyword>
	<keyword>chemical ablation</keyword>
	<keyword>Irreversible electroporation</keyword>
</DOC>